What is the pathophysiology, symptoms, diagnosis, management, and differential diagnoses of molluscum contagiosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Molluscum Contagiosum: Comprehensive Overview

Pathophysiology

Molluscum contagiosum is caused by a poxvirus (molluscum contagiosum virus, MCV) that infects epidermal keratinocytes through direct skin-to-skin contact, fomites, or autoinoculation. 1, 2 The virus replicates within the cytoplasm of infected cells, leading to characteristic cellular proliferation and the formation of umbilicated papules. 2

  • Transmission occurs through direct contact with infected individuals, sharing towels and personal items, or exposure in communal water settings like swimming pools and hot tubs. 1
  • The virus remains infectious throughout the entire course of lesions, which can persist from 6 months to 5 years without treatment. 1, 2
  • Self-inoculation is common, leading to spread across body surfaces through scratching or touching lesions. 1

Clinical Presentation and Symptoms

The hallmark presentation consists of skin-colored, whitish, or pink papules (2-6 mm diameter) with a shiny surface and central umbilication, most commonly affecting the trunk, face, and extremities in children. 1, 3, 2

Typical Features:

  • Firm, rounded, dome-shaped papules that develop central umbilication as they mature. 3
  • In children: trunk, face, and extremities are most commonly affected. 3
  • In adults: genital region is predominantly involved, suggesting sexual transmission. 2
  • Most lesions are asymptomatic, though pain, itching, and redness may occur. 1, 3

Associated Complications:

  • Conjunctivitis when lesions are located on or near the eyelids (may be mild to severe with follicular reaction). 1, 3
  • Perilesional eczema (eczematous dermatitis around lesions). 2
  • Bacterial superinfection. 3, 2

Red Flags for Immunocompromised State:

  • Multiple large lesions with minimal conjunctival inflammation strongly suggest immunodeficiency and warrant HIV screening. 1, 4, 5
  • Atypical presentations including giant, disseminated, necrotic, polypoidal, nodular forms, pseudocysts, or abscesses. 1
  • Extensive disease with prolonged course. 5

Diagnosis

Diagnosis is primarily clinical based on the characteristic appearance of umbilicated papules; dermoscopy can aid diagnosis when umbilication is not visible. 1, 2

Diagnostic Approach:

  • Look for shiny, dome-shaped papules with central umbilication on typical body sites. 1
  • Early lesions may appear as simple dome-shaped papules without central depression. 1
  • Assess distribution pattern and look for associated findings (conjunctivitis, perilesional eczema, inflammatory reactions). 1
  • White material can be expressed from lesions on compression (Henderson-Paterson bodies). 6

When Umbilication is Absent:

  • Dermoscopy is useful for identifying characteristic features in early, inflamed, or atypical lesions. 1, 2
  • Consider confocal microscopy or skin biopsy if diagnostic uncertainty persists. 2
  • In immunocompromised patients with atypical presentations, referral to dermatology is recommended. 1

Critical Differential:

  • In HIV patients, cryptococcal infection can present with umbilicated papules resembling molluscum contagiosum and must be excluded. 1, 3

Management

Physical removal methods (curettage, excision, cryotherapy) are first-line therapy for symptomatic lesions, multiple lesions, or those causing conjunctivitis, with cryotherapy achieving 93% complete response. 1, 4

Treatment Algorithm:

For Limited, Asymptomatic Disease:

  • Watchful waiting is reasonable as spontaneous resolution typically occurs in 6-12 months (though can take up to 4-5 years). 1
  • Consider active treatment to prevent transmission and reduce autoinoculation risk. 2

For Symptomatic, Multiple, or Periocular Lesions:

  • Cryotherapy with liquid nitrogen: 93% complete response rate, applied to achieve visible freezing extending slightly beyond lesion margin. 1
  • Curettage (incision and curettage, simple excision, or excision with cautery): equally effective first-line options. 1, 4
  • 10% potassium hydroxide solution: similar efficacy to cryotherapy (86.6% vs 93.3% complete response) with better cosmetic results due to lower hyperpigmentation risk. 1

Critical Treatment Principles:

  • Identify and treat ALL lesions, including nascent ones, during initial treatment to reduce recurrence risk. 1, 4
  • Reducing viral load allows host immune response to eliminate residual virus. 1, 4
  • For periocular lesions with conjunctivitis, physical removal is imperative; conjunctivitis may require several weeks to resolve after lesion elimination. 1, 4

Treatment Considerations by Modality:

Cryotherapy:

  • No anesthesia is typically used as it has not shown benefit. 1
  • Common adverse effects: postinflammatory hyperpigmentation (most common, may persist 6-12 months), erythema, vesicle formation, burning pain. 1
  • Avoid treating sensitive areas (eyelids, lips, nose, ears) due to higher complication risk. 1

Potassium Hydroxide:

  • Better cosmetic outcomes than cryotherapy, particularly for facial lesions or darker skin tones. 1

Cantharidin:

  • Effective in observational studies, though randomized controlled trial evidence is limited. 1

What NOT to Use:

  • Imiquimod has NOT shown benefit compared to placebo in randomized controlled trials and is NOT recommended by the American Academy of Pediatrics. 1 (Note: Despite some observational reports suggesting efficacy 7, the highest quality evidence from FDA-requested RCTs does not support its use.)

Special Populations:

Immunocompromised Patients:

  • Consider screening for HIV if extensive disease with minimal inflammation is present. 1, 4
  • Referral to dermatology for extensive or recalcitrant disease. 1
  • Rule out cryptococcal infection in HIV patients with atypical presentations. 1

Follow-up:

  • Not usually necessary unless conjunctivitis persists or new lesions develop. 1, 4
  • Monitor for resolution of conjunctivitis after periocular lesion removal. 1

Patient Counseling

Transmission Prevention:

  • Hand hygiene with alcohol-based disinfectant or soap and water is the most important prevention method. 1
  • Avoid direct skin-to-skin contact with infected individuals. 1
  • Do not share towels, clothing, personal items, or equipment. 1
  • Avoid scratching lesions to prevent autoinoculation and spread. 1

Water Exposure:

  • Cover all lesions with waterproof bandages if water exposure is unavoidable. 1
  • Limit exposure to swimming pools associated with known outbreaks. 1
  • Hot tubs present higher transmission risk than standard pools due to warmer water, closer proximity, and shared seating surfaces. 1
  • Return to communal water activities only when all lesions have completely resolved and no new lesions have appeared for several weeks. 1

Natural Course:

  • Lesions typically persist 6-12 months but can last up to 4-5 years without treatment. 1, 3
  • Spontaneous resolution occurs in most immunocompetent individuals. 1
  • Erythema around lesions may represent normal inflammatory response as the immune system clears the virus. 1
  • Lesions remain infectious throughout their entire course. 1

Treatment Expectations:

  • Treatment aims to reduce transmission risk, prevent complications, and address cosmetic concerns. 2
  • Treating all visible lesions, including early ones, reduces recurrence risk. 1
  • Some treatments may cause temporary hyperpigmentation, particularly in darker skin tones. 1

Differential Diagnoses

Primary Differentials:

  • Cryptococcal infection (in HIV patients): umbilicated papules that closely mimic molluscum contagiosum. 1, 3
  • Verruca vulgaris (common warts): lack central umbilication, have rough surface. 2
  • Basal cell carcinoma: typically in older adults, pearly appearance, may have central ulceration rather than umbilication.
  • Keratoacanthoma: rapid growth, larger size, central keratin plug.

In Immunocompromised Patients:

  • Disseminated fungal infections (histoplasmosis, cryptococcosis). 1
  • Cutaneous lymphoma.
  • Atypical mycobacterial infections.

In Children:

  • Syringomas: small, firm papules without umbilication, typically periorbital.
  • Milia: smaller, white, superficial cysts without umbilication.
  • Closed comedones: associated with acne, different distribution.

Common Pitfalls:

  • Failing to treat nascent lesions during initial treatment is a frequent cause of recurrence. 1
  • Not recognizing extensive disease with minimal inflammation as a sign of immunodeficiency. 1, 4
  • Overlooking periocular lesions that require active treatment to prevent ocular complications. 1

References

Guideline

Molluscum Contagiosum Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Physical Examination Findings of Molluscum Contagiosum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Molluscum Contagiosum in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is genital molluscum (a sexually transmitted infection) typically painful?
What is the gold standard treatment for Molluscum contagiosum?
What is the most likely diagnosis for a 2-year-old boy with a history of atopic dermatitis, presenting with multiple flesh-colored, dome-shaped, pearly lesions with central depressions on his arms, which are different from his usual atopic dermatitis in appearance and location, and are not itchy?
What is the treatment for molluscum contagiosum on the vulva?
What are the treatment options for Molluscum contagiosum (a viral skin infection)?
What is the most appropriate next step in managing a 12-week pregnant patient with a monochorionic twin pregnancy and evidence of twin-to-twin transfusion syndrome (TTTS)?
What is the treatment for folliculitis on the scalp?
Would increasing the dosage of gabapentin (Neurontin) be beneficial for a patient with a history of anxiety, panic attacks, and manic episodes, who has experienced improved anxiety symptoms with gabapentin in the past, but now suffers from sleep disturbances and nocturnal mania?
What is the preferred treatment between Amiodarone and Digoxin (digitalis) for a patient with atrial fibrillation (AFib) and fast ventricular response, particularly in those with a history of heart failure or reduced ejection fraction?
Is erythromycin (antibiotic) ointment effective for treating folliculitis on the scalp?
What is the recommended management for a patient diagnosed with scarlet fever, considering age, medical history, and severity of symptoms such as sore throat, fever, and rash?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.